Table 2 Baseline characteristics of patients
From: Trends in mortality and loss to follow-up in HIV care at the Nkongsamba Regional hospital, Cameroon
Factor | Number | Factor | Number |
|---|---|---|---|
N (%) | N (%) | ||
Calendar year | |||
2005 | 103(5.7) | Immune deficiency | |
2006 | 208(11.4) | None | 234(13.4) |
2007 | 401(22.0) | Mild | 186(10.7) |
2008 | 483(26.5) | Moderate | 449(25.8) |
2009 | 351(19.2) | Severe | 871(50.1) |
2010 | 278(15.2) | Total | 1740(100.0) |
Total | 1824(100.0) | ||
Current age groups (years) | |||
15 – 24 | Haemoglobin level(g/dl) | ||
25 – 34 | > = 10 | 848(61.1) | |
35 – 44 | 671(36.3) | <10 | 539(38.9) |
45+ | 579(31.3) | Total | 1387(100.0) |
Total | 450(24.3) | ||
1824(100.0) | |||
Gender | Alanine amino- | ||
Females | 1284(70.4) | Transferase(IU/l) | |
Males | 540(29.6) | <50 | 1344(98.3) |
Total | 1824(100.0) | > = 50 | 23(1.7) |
Total | 1367(100.0) | ||
Region | Aspartine amino- | ||
Littoral | 1661(92.3) | Transferase(IU/l) | |
South-West | 44(2.4) | <45 | 1311(95.9) |
West | 79(4.4) | > = 45 | 56(4.1) |
Other | 16(0.9) | Total | 1367(100.0) |
Total | 1800(100.0) | ||
Marital status | |||
Single | 568(31.8) | Fasting blood sugar(mg/dl) | |
Monogamous | 636(35.6) | <126 | 996(94.1) |
Polygamous | 152(8.5) | > = 126 | 62(5.9) |
Divorced | 141(7.9) | Total | 1058(100.0) |
Widowed | 289(16.2) | ||
Total | 1786(100.0) | ||
Partner HIV | |||
Negative | 217(12.1) | Creatinine level(mg/l) | |
Positive-ART | 220(12.2) | <=15 | 125(82.8) |
Positive + ART | 99(5.5) | >15 | 26(17.2) |
Unknown | 1262(70.2) | Total | 151(100.0) |
Total | 1798(100.0) | ||
Occupation | NNRTI Regimen | ||
Lower grade | 1668(93.0) | EFV-based | 395(33.7) |
Higher grade | 126(7.0) | NVP-based | 779(66.3) |
Total | 1794(100) | Total | 1174(100.0) |
NRTI Regimen | |||
Distance(km) | |||
≤5 | 781(43.5) | ABC/TDF-based | 19(1.0) |
>5 | 1015(56.5) | AZT-based | 527(28.9) |
Total | 1796(100.0) | D4T-based | 628(34.4) |
None | 650(35.6) | ||
Total | 1824(100.0) | ||
Alcohol | Drug change | ||
No | 687(39.0) | No | 804(68.3) |
Yes | 1077(61.0) | Yes | 374(31.7) |
Total | 1764(100.0) | Total | 1178(100.0) |
Smoking | Cotrimoxazole use | ||
No | 1495(84.7) | No | 72(5.4) |
Yes | 269(15.3) | Yes | 1251(94.6) |
Total | 1764(100.0) | Total | 1323(100.0) |
WHO Clinical stage | |||
I | 404(22.9) | ||
II | 266(15.1) | ||
III | 955(54.1) | ||
IV | 140(7.9) | ||
Total | 1765(100.0) |